<p>Nov 20 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Thursday:</p>
<p>Medical device maker Solventum &lt;</p>
<h3>SOLV.N</h3>
<ul>
<li>said it would acquire privately held Acera Surgical for up to $850 million to expand its wound-care portfolio.</li>
</ul>
<p>Enterprise Products Partners &lt;</p>
<h3>EPD.N</h3>
<ul>
<li>said that Exxon Mobil &lt;</li>
</ul>
<h3>XOM.N</h3>
<ul>
<li>will buy a 40% stake in its Bahia natural gas liquids pipeline and help expand the system to handle growing Permian Basin volumes.</li>
</ul>
<p>Abbott &lt;</p>
<h3>ABT.N</h3>
<ul>
<li>said it would buy cancer-test maker Exact Sciences &lt;</li>
</ul>
<h3>EXAS.O</h3>
<ul>
<li>in a deal valued at up to $23 billion, including debt, marking one of its largest acquisitions in nearly a decade and its first major push into cancer screening.</li>
</ul>
<p>Insurer Generali &lt;</p>
<h3>GAS.MI</h3>
<blockquote>
<p>, Milan-listed BFF Bank &lt;</p>
</blockquote>
<h3>BFF.MI</h3>
<ul>
<li>and France’s BPCE have advanced to the second round of bidding to acquire European life-insurance consolidator GamaLife from Apax Partners, two sources familiar with the matter said.</li>
</ul>
<p>Palo Alto Networks  (PANW.O)  said it will buy cloud management and monitoring company Chronosphere for $3.35 billion, as the cybersecurity firm looks to strengthen its AI offerings.</p>

EXAS

<p>Medical device maker Solventum will acquire Acera Surgical for up to $850 million. Enterprise Products Partners and Exxon Mobil will expand the Bahia natural gas liquids pipeline. Abbott will buy Exact Sciences for up to $23 billion. Generali, BFF Bank, and BPCE advance in bidding for GamaLife. Palo Alto Networks will acquire Chronosphere for $3.35 billion.</p>

- Medical device maker Solventum will acquire Acera Surgical for up to $850 million to enhance its wound-care portfolio.  
- Exxon Mobil is set to purchase a 40% stake in Enterprise Products Partners' Bahia natural gas liquids pipeline to support expansion for Permian Basin volumes.  
- Abbott plans to acquire Exact Sciences for up to $23 billion, marking a significant move into cancer screening, while Generali, BFF Bank, and BPCE are in the second round of bidding for GamaLife.

Deals of the day-Mergers and acquisitions